US 11,903,602 B2
Uterine fibroid tissue removal device
Roy Hewitt Sullivan, Marlborough, MA (US); Albert Chun-Chi Chin, Marlborough, MA (US); Eric Karl Litscher, Marlborough, MA (US); William Lucas Churchill, Marlborough, MA (US); Ronald David Adams, Marlborough, MA (US); William Harwick Gruber, Marlborough, MA (US); and David Jacobs, Marlborough, MA (US)
Assigned to Hologic, Inc., Marlborough, MA (US)
Filed by HOLOGIC, INC., Marlborough, MA (US)
Filed on Jun. 25, 2021, as Appl. No. 17/357,993.
Application 17/357,993 is a continuation of application No. 16/190,770, filed on Nov. 14, 2018, granted, now 11,045,217.
Application 16/190,770 is a continuation of application No. 15/365,502, filed on Nov. 30, 2016, granted, now 10,130,389, issued on Nov. 20, 2018.
Application 15/365,502 is a continuation of application No. 14/983,024, filed on Dec. 29, 2015, granted, now 9,539,019, issued on Jan. 10, 2017.
Application 14/983,024 is a continuation of application No. 14/680,276, filed on Apr. 7, 2015, granted, now 9,339,288, issued on May 17, 2016.
Application 14/680,276 is a continuation of application No. 12/432,686, filed on Apr. 29, 2009, granted, now 9,095,366, issued on Aug. 4, 2015.
Prior Publication US 2022/0047291 A1, Feb. 17, 2022
Int. Cl. A61B 17/32 (2006.01); A61B 17/3205 (2006.01); A61M 1/00 (2006.01); A61B 17/42 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61B 17/3201 (2006.01); A61B 17/3207 (2006.01); A61B 17/29 (2006.01); A61B 18/14 (2006.01); A61B 17/22 (2006.01)
CPC A61B 17/32002 (2013.01) [A61B 17/00234 (2013.01); A61B 17/3205 (2013.01); A61B 17/320016 (2013.01); A61B 17/32053 (2013.01); A61B 17/3415 (2013.01); A61B 17/42 (2013.01); A61M 1/842 (2021.05); A61B 17/3201 (2013.01); A61B 17/32056 (2013.01); A61B 17/320725 (2013.01); A61B 17/320783 (2013.01); A61B 17/3462 (2013.01); A61B 2017/0046 (2013.01); A61B 2017/0073 (2013.01); A61B 2017/00331 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/00424 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00685 (2013.01); A61B 2017/22078 (2013.01); A61B 2017/22079 (2013.01); A61B 2017/2905 (2013.01); A61B 2017/320004 (2013.01); A61B 2017/320024 (2013.01); A61B 2017/320028 (2013.01); A61B 2017/320064 (2013.01); A61B 2017/320775 (2013.01); A61B 2017/347 (2013.01); A61B 2017/3466 (2013.01); A61B 2017/4216 (2013.01); A61B 2018/1407 (2013.01); A61B 2217/005 (2013.01); A61B 2217/007 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A tissue removal system, comprising:
an introducer having a lumen extending through the introducer, the introducer being configured for transcervical insertion into a uterus; and
a tissue removal device, the tissue removal device comprising
a housing,
a tubular member having a proximal end coupled to the housing and a distal end, the tubular member configured for movement through the introducer lumen, and
a position indicator extending radially outward from an outer wall of a proximal portion of the tubular member,
wherein a proximal portion of the introducer lumen is configured to accommodate passage of the tubular member therethrough, while providing sufficient interference with the position indicator to impart feedback to a user grasping the housing of the tissue removal device indicating that the proximal portion of the tubular member has entered into the proximal portion of the introducer lumen without prohibiting further travel of the tubular member distally through the introducer lumen.